Why Inspect? parenteral injecton visual inspection shandong hawkeye US FDA 483 Themes
 Patient Risk  – Physiological Implications  • Particles  – Chemical and Microbiological Implications  • Particles, Container Integrity  • Compendial Requirements  – Pharmacopeias  • Regulatory Requirements  • Process Knowledge and Continuous Process  Improvement • Must establish a maximum allowable reject rate.  • Must control reinspection of product, including when appropriate, inspection conditions and number of reinspections permitted.  • Inspectors must be trained, and training  documented.  • Inspectors must be periodically requalified.  • Training and qualification conditions must align  with routine 100% inspection conditions.  • Address inspection fatigue during qualification.  • Must use statistically sound sampling plan(s) for AQL inspection.  -0086-13589838190